Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schiff

Showing results (101-110 of 305) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|August 27, 2009
Neurological adverse effects caused by cytotoxic and targeted therapiesDavid Schiff, Patrick Y Wen, Martin J van den Bent
Expert Opinion on Biological Therapy|May 15, 2008
Cintredekin besudotox in treatment of malignant gliomaMelike Mut, Jonathan H Sherman, Mark E Shaffrey, et al.
Neurology|July 21, 2010
Optic neuropathy in patients with glioblastoma receiving bevacizumabMarc C Chamberlain, Jeffrey Raizer, David Schiff, et al.
Neurosurgery Clinics of North America|March 18, 2004
Intraventricular gliomasAaron S Dumont, Elana Farace, David Schiff, et al.
JCO Precision Oncology|June 1, 2023
Fatal Intracranial Hemorrhage With Belzutifan in von Hippel-Lindau Disease-Associated Hemangioblastoma: A Case ReportZabila Saeed, Azka Tasleem, Ashok Asthagiri, et al.
Neuro-Oncology|August 12, 2021
Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?Jasmin Jo, Joseph Donahue, Guneet Sarai, et al.
Neuro-Oncology Practice|January 20, 2023
Navigating disability insurance in the American healthcare system for the low-grade glioma patientLalanthica Yogendran, Mark Rudolf, Drew Yeannakis, et al.
JCO Oncology Practice|April 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update Clinical InsightsNimish A Mohile, Andrew B Lassman, David Schiff, et al.
Idrugs : the Investigational Drugs Journal|February 4, 2010
XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLCYing Zhang, Fadila Guessous, Alex Kofman, et al.
Neuro-Oncology Practice|May 15, 2023
Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphomaJoy C Zhang, Matthew J Stotts, Bethany Horton, et al.
Pageof 31

Showing results (101-110 of 305) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|August 27, 2009
Neurological adverse effects caused by cytotoxic and targeted therapiesDavid Schiff, Patrick Y Wen, Martin J van den Bent
Expert Opinion on Biological Therapy|May 15, 2008
Cintredekin besudotox in treatment of malignant gliomaMelike Mut, Jonathan H Sherman, Mark E Shaffrey, et al.
Neurology|July 21, 2010
Optic neuropathy in patients with glioblastoma receiving bevacizumabMarc C Chamberlain, Jeffrey Raizer, David Schiff, et al.
Neurosurgery Clinics of North America|March 18, 2004
Intraventricular gliomasAaron S Dumont, Elana Farace, David Schiff, et al.
JCO Precision Oncology|June 1, 2023
Fatal Intracranial Hemorrhage With Belzutifan in von Hippel-Lindau Disease-Associated Hemangioblastoma: A Case ReportZabila Saeed, Azka Tasleem, Ashok Asthagiri, et al.
Neuro-Oncology|August 12, 2021
Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?Jasmin Jo, Joseph Donahue, Guneet Sarai, et al.
Neuro-Oncology Practice|January 20, 2023
Navigating disability insurance in the American healthcare system for the low-grade glioma patientLalanthica Yogendran, Mark Rudolf, Drew Yeannakis, et al.
JCO Oncology Practice|April 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update Clinical InsightsNimish A Mohile, Andrew B Lassman, David Schiff, et al.
Idrugs : the Investigational Drugs Journal|February 4, 2010
XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLCYing Zhang, Fadila Guessous, Alex Kofman, et al.
Neuro-Oncology Practice|May 15, 2023
Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphomaJoy C Zhang, Matthew J Stotts, Bethany Horton, et al.
Pageof 31